Ares Financial Consulting’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDYA
BBA
Ares Financial Consulting's IDYA Position: Q3 2026 in Review
Ares Financial Consulting sold out of IDEAYA Biosciences (IDYA) in Q3 2026, closing a stake of 25 shares — an estimated $932 sold.
Ares Financial Consulting first reported a position in IDYA in Q2 2026 and held it in 1 quarter. The position peaked at $932 in Q2 2026. 280 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.
- Ares Financial Consulting reported no remaining IDEAYA Biosciences position as of Q3 2026 after selling out during the quarter.
- Ares Financial Consulting sold 25 IDEAYA Biosciences shares in Q3 2026, an estimated $932.
- Ares Financial Consulting first reported a position in IDEAYA Biosciences in Q2 2026 and held it in 1 quarter.
- Ares Financial Consulting's IDEAYA Biosciences position peaked at $932 in Q2 2026.
- 280 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.
Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.